| 18/12/2015 |
Change of Director’s Interest Notice – Maria Halasz |
| 01/12/2015 |
Key Antibody Patent Granted in Europe |
| 24/11/2015 |
Japanese patent granted for use of MK for hair growth |
| 12/11/2015 |
AGM Presentation to Shareholders |
| 12/11/2015 |
Results of Annual General Meeting |
| 30/10/2015 |
Company Secretary Appointment / Resignation |
| 27/10/2015 |
Appendix 4C – quarterly |
| 12/10/2015 |
Cellmid 2015 Annual Report to Shareholders |
| 12/10/2015 |
Notice of AGM / Proxy Form |
| 28/09/2015 |
Announcement Date of AGM |
| 15/09/2015 |
Cleansing Statement and Appendix 3B |
| 09/09/2015 |
EGM Presentation |
| 09/09/2015 |
Results of EGM |
| 31/08/2015 |
Appendix 4E and Preliminary Financial Report |
| 31/08/2015 |
Appendix 4G and Corporate Governance Statement |
| 27/08/2015 |
Cellmid Launching Major Advertising Campaign |
| 13/08/2015 |
Change of Director’s Interest Notice – Dr Edward Fintan Walton |
| 12/08/2015 |
Cellmid appoints EAS to support US Strategy |
| 10/08/2015 |
Notice of Extraordinary General Meeting and Proxy Form |
| 06/08/2015 |
CDY Newsletter August 2015 |
| 05/08/2015 |
Cleansing Notice and Appendix 3B |
| 30/07/2015 |
Appendix 4C – Quarterly |
| 30/07/2015 |
Cellmid Capital Raising |
| 28/07/2015 |
Trading Halt |
| 23/07/2015 |
Initial Director’s Interest Notice – Dr Fintan Walton |
| 21/07/2015 |
Cellmid Appoints Dr Fintan Walton as Director |
| 15/07/2015 |
Transcript of Investor Conference Call |
| 09/07/2015 |
Cellmid Revenue Guidance Upgrade |
| 07/07/2015 |
Dr Bryce Vissel to Chair Cellmid’s Scientific Advisory Board |
| 01/07/2015 |
Final Director’s Interest Notice – G Kaufman |
| 01/07/2015 |
Final Director’s Interest Notice – M Rogers |
| 01/07/2015 |
Initial Director’s Interest Notice – B Gordon |
| 30/06/2015 |
Change of Registry Address |
| 29/06/2015 |
US Patent for Anti-Midkine Antibodies Granted |
| 23/06/2015 |
Cellmid Announces Brain Cancer Program |
| 17/06/2015 |
Cellmid Invited to Present at Breakfast @ BIO |
| 15/06/2015 |
Positive Toxicology Study Results for CAB102 |
| 02/06/2015 |
Cellmid Signs Agreement with Maywufa |
| 26/05/2015 |
Director Appointment / Resignation |
| 19/05/2015 |
Appendix 3B |
| 15/05/2015 |
Cellmid Secures $1M Loan Funding |
| 29/04/2015 |
Appendix 4C – quarterly |
| 15/04/2015 |
Positive Clinical Results for Cellmid Hair Growth Product |
| 13/04/2015 |
Cellmid to present MK at World Congress of Angiogenesis |
| 31/03/2015 |
Company Secretary Appointment/Resignation |
| 10/03/2015 |
Change of Director’s Interest Notice |
| 04/03/2015 |
Broker Meets Biotech Presentation |
| 24/02/2015 |
Appendix 4D and Half Year Accounts |
| 11/02/2015 |
Cellmid Newsletter February Issue |
| 28/01/2015 |
Appendix 4C – quarterly |
| 21/01/2015 |
USA Patent Granted for MK Treatment of Heart Failure |
| 12/01/2015 |
Australian Patent Granted for Use of Midkine for Hair Growth |
